7.435
전일 마감가:
$7.13
열려 있는:
$7.27
하루 거래량:
513.27K
Relative Volume:
0.41
시가총액:
$344.75M
수익:
$217.11M
순이익/손실:
$-651.19M
주가수익비율:
-0.5724
EPS:
-12.99
순현금흐름:
$-387.26M
1주 성능:
+9.50%
1개월 성능:
+5.61%
6개월 성능:
-23.59%
1년 성능:
-65.68%
깅코 바이오웍스 홀딩스 Stock (DNA) Company Profile
명칭
Ginkgo Bioworks Holdings Inc
전화
(877) 442-5362
주소
27 DRYDOCK AVENUE, BOSTON
DNA을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
DNA
Ginkgo Bioworks Holdings Inc
|
7.438 | 397.43M | 217.11M | -651.19M | -387.26M | -12.99 |
![]()
ONC
Beone Medicines Ltd Adr
|
252.87 | 25.76B | 3.81B | -644.79M | -669.77M | -6.24 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
449.31 | 114.53B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
AKTX
Akari Therapeutics Plc Adr
|
1.3401 | 40.54M | 0 | 0 | 0 | 0.00 |
![]()
VRNA
Verona Pharma Plc Adr
|
84.73 | 6.44B | 0 | -153.72M | -103.81M | -2.00 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
495.14 | 65.13B | 14.09B | 4.50B | 2.96B | 39.28 |
깅코 바이오웍스 홀딩스 Stock (DNA) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-05-15 | 다운그레이드 | BTIG Research | Neutral → Sell |
2024-05-10 | 다운그레이드 | William Blair | Mkt Perform → Underperform |
2023-11-14 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
2023-11-09 | 다운그레이드 | BTIG Research | Buy → Neutral |
2023-06-02 | 다운그레이드 | Goldman | Neutral → Sell |
2023-05-11 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
2022-11-29 | 개시 | Berenberg | Buy |
2022-10-04 | 개시 | Morgan Stanley | Equal-Weight |
2022-05-18 | 다운그레이드 | BofA Securities | Neutral → Underperform |
2022-03-02 | 재개 | Cowen | Outperform |
2022-02-23 | 개시 | Goldman | Neutral |
2022-02-01 | 개시 | BofA Securities | Neutral |
2022-01-28 | 개시 | BofA Securities | Buy |
2022-01-07 | 개시 | BTIG Research | Buy |
2021-11-29 | 개시 | Jefferies | Buy |
2021-10-13 | 개시 | Raymond James | Outperform |
2021-10-12 | 개시 | William Blair | Outperform |
2021-09-20 | 개시 | HSBC Securities | Buy |
모두보기
깅코 바이오웍스 홀딩스 주식(DNA)의 최신 뉴스
Top 5 CRISPR Companies To Invest In (June 2025) - Securities.io
Northern Trust Corp Buys 9,791 Shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - Defense World
(DNA) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Millennium Management LLC Has $6.58 Million Stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - Defense World
Ginkgo Bioworks Partners with HaDEA in Up to €24 Million Consortium Project to Deliver Next-Generation 'Agnostic Diagnostics' for Respiratory Viruses at the Point of Care - Quantisnow
Ginkgo Bioworks: Cost-Cutting Efforts Aren't Enough (NYSE:DNA) - Seeking Alpha
Major Moves And Shakes In Health Care Sector - Finimize
Sector Update: Health Care - marketscreener.com
Ginkgo Bioworks announces CFO transition - MSN
Ginkgo Bioworks (DNA) Announces CFO Transition - GuruFocus
Ginkgo Bioworks CFO Mark Dmytruk to Resign, Steven Coen Appointed as New Finance Chief - marketscreener.com
Ginkgo Bioworks Announces Appointment Of Steven Coen As Chief Financial Officer - marketscreener.com
Charles River Laboratories (CRL): Leadership Change at Ginkgo Bi - GuruFocus
Charles River Laboratories (CRL): Leadership Change at Ginkgo Bioworks | CRL Stock News - GuruFocus
Ginkgo Bioworks Announces Appointment of Steven Coen as Chief Financial Officer - StreetInsider
Ginkgo Bioworks Promotes 30-Year Finance Expert to CFO Role, Maintains 2026 EBITDA Target - Stock Titan
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) is a favorite amongst institutional investors who own 56% - Yahoo Finance
When the Price of (DNA) Talks, People Listen - news.stocktradersdaily.com
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Moves -1.94%: What You Should Know - MSN
Twist Bioscience and Ginkgo Bioworks update 2022 partnership - MSN
Ginkgo outlines $250M cost reduction target and tools expansion in Q1 2025 update - MSN
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) First-Quarter Results: Here's What Analysts Are Forecasting For This Year - simplywall.st
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Acquired by Barclays PLC - Defense World
Ginkgo Bioworks Holdings, Inc. (DNA): Among Nicholas J. Pritzker’s Stock Picks with Huge Upside Potential - MSN
Billionaire Nicholas J. Pritzker’s 8 Stocks with Huge Upside Potential - Insider Monkey
GINKGO BIOWORKS HOLDINGS, INC. F/K/A SOARING EAGLE ACQUISITION CORP. (NYSE: DNA, SRNG) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Cla - ACCESS Newswire
Twist Bioscience and Ginkgo Bioworks Revise Collaboration - Stock Titan
GINKGO BIOWORKS HOLDINGS, INC. F/K/A SOARING EAGLE ACQUISITION CORP. (NYSE:DNA, SRNG) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Cla - ACCESS Newswire
Scientists Discover Bacteria That Breathes Electricity — A Game-Changer for Green Energy - Securities.io
Twist Bioscience and Ginkgo Bioworks update DNA supply deal - Investing.com
Ginkgo Bioworks Earnings Call: Optimism Amid Challenges - TipRanks
How to Take Advantage of moves in (DNA) - news.stocktradersdaily.com
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q1 2025 Earnings Call Transcript - Insider Monkey
Ginkgo Bioworks Q1 2025 Earnings Call Transcript - MarketBeat
Ginkgo Bioworks Holdings Inc (DNA) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Ginkgo Bioworks Reports Strong Q1 2025 Growth - TipRanks
Ginkgo Bioworks Q1 2025 slides: Revenue grows 27% as cost-cutting advances - Investing.com Canada
Ginkgo Bioworks Holdings Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Earnings call transcript: Ginkgo Bioworks’ Q1 2025 revenue rises, stock slips - Investing.com Canada
Ginkgo Bioworks (DNA) Surpasses Revenue Expectations with Strong Q1 Performance | DNA Stock News - GuruFocus
Ginkgo Bioworks (DNA) Anticipates Volatility Ahead of Earnings R - GuruFocus
Ginkgo Bioworks Reports First Quarter 2025 Financial Results - The Malaysian Reserve
Ginkgo Bioworks Holdings, Inc. (DNA) Reports Q1 Loss, Tops Revenue Estimates - Nasdaq
Ginkgo (DNA) Updates Revenue Projections for FY25 | DNA Stock News - GuruFocus
Ginkgo Bioworks Holdings, Inc. SEC 10-Q Report - TradingView
Ginkgo Bioworks Q1 2025 Financial Results - TradingView
Ginkgo Bioworks Reports First Quarter 2025 Financial Results – Company Announcement - Financial Times
Ginkgo Bioworks (DNA) Anticipates Volatility Ahead of Earnings Report | DNA Stock News - GuruFocus
Ginkgo Bioworks Holdings Inc expected to post a loss of $1.77 a shareEarnings Preview - TradingView
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Slides as Market Rises: Facts to Know Before You Trade - MSN
Ginkgo Bioworks and XpresCheck Receive Award to Expand CDC's Traveler-Based SARS-CoV-2 Genomic Surveillance Program In U.S. Airports - Barchart.com
깅코 바이오웍스 홀딩스 (DNA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):